The blog is a place to post your thoughts and ideas.

New antibiotic use visualizations on ResistanceMap bring to light large variations in outpatient antibiotic dispensing patterns across the United States.  Residents in West Virginia, for example, take over twice the number of antibiotics per capita than people living in western states like Alaska and Oregon.  This infographic breaks down the rates by state, showing a striking pattern of intensive use in the U.S. Southeast in 2006-2007.

Two big updates this week.  First, ResistanceMap has released its first ever interactive visualizations on antibiotic use.  The new maps show trends in outpatient prescribing across the United States over time, and viewers can sort data by geography (at the state level) and/or antibiotic class.  You can check out the new visualizations in the "antibiotic use" module found here.

CDC's annual Get Smart About Antibiotics week has arrived and the agency has kicked it off by announcing a pilot program to track antibiotic use in hospitals.  The mechanism works through the National Healthcare Safety Network and will initially target 70 hospitals through four health departments.

New data released in Pediatrics this week describes the prevalence of antibiotic prescribing in pediatric ambulatory care visits.  Antibiotics are prescribed in just over 20% of such visits, with a majority of these prescriptions for respiratory conditions.  Broad-spectrum antibiotic use is prevalent, accounting for 50% of all prescriptions.

Last Wednesday the CDC released an upbeat piece of epidemiological news: rates of four common types of nosocomial infections decreased at an impressive pace in 2010, bringing hospitals ever closer to the nine milestones set in the Department of Health and Human Services’ Action Plan to Prevent Healthcare-Associated Infections.

ResistanceMap - an online tool for visualizing antibiotic resistance from Extending the Cure - launches a second edition today with more bacteria-antibiotic combinations, U.S.-Canada-Europe comparisons of resistance trends, and lots of opportunities to interact with the data.  Read the press release below, and take a look at some initial coverage on The Scientist and the Washington Post's

Megan McArdle’s recent take on antibiotic resistance in The Atlantic is a smart look at the incentives that skew the debate on antibiotics in the U.S. – namely the fact that these wonder drugs currently play out a classic tragedy of the commons scenario.

At the 1st Global Forum on Bacterial Infections we’ll be piloting “hands-on sessions” focused on the more practical aspects of containing antibiotic resistance.  These workshops for researchers, clinicians, and policymakers are designed to be small, intensive, and interactive.  Space is limited, so we’ve opened up pre-registration on the Global Forum website (click on a hands-on session and you’ll see the form to sign up).  There are six se

The CDDEP blog will be transitioning over the next month to exclusive coverage of antimicrobial resistance in anticipation of  the 1st Global Forum on Bacterial Infections.  I'll be re-posting all CDDEP pieces here on the ETC blog: